A major focus of research for the next years will be to understand on a more detailed level the molecular mechanisms driving the reprogramming of somatic cells to pluripotent IPS cells. 1. Single-cell analysis of gene expression during cellular reprogramming An unresolved issue is whether activation of specific genes can predict early in the reprogramming process whether a given cell will develop into an iPS cell. Single RNA molecule detection methods will be Used to: a. assess whether a hierarchical program of gene expression leads to IPS cell formation or whether the process is entirely stochastic as suggested by previous observations. b. define markers that at early stages of reprogramming allow the prospective identification of cells that will generate IPS cells. For this, GFP will be inserted into candidate genes to give a marker for prospective isolation of IPS precursors. 2. Stoichiometry of reprogramming factors and quality of iPS cells mRNA mediated reprogramming will be used to systematically titrate the various factors for investigating the effect of factor stoichiometry on the biological properties of the IPS cells. This will allow the optimization of reprogramming with the goal of generating high quality genetically unmodified iPS cells. 3. Transdifferentiation of somatic cells to cells of different lineages Different somatic donor cells such as liver cells and skin keratinocytes will be used for direct conversion into neural precursors and neurons. Stringent reporters will allow the retrospective confirmation of the endodermal arid ectodermal donor cell type.

Public Health Relevance

The 'disease in the dish' approach, based on the IPS technology, is attractive for studying human diseases and for developing novel therapies. However, epigenetic and biological differences between individual IPS cells pose potentially serious hurdles for implementing this approach for research and therapy. This program uses stringent criteria to define the parameters that assure the generation of high quality iPS cells.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HD045022-13
Application #
8849766
Study Section
Special Emphasis Panel (NSS)
Program Officer
Ravindranath, Neelakanta
Project Start
2003-07-28
Project End
2016-05-31
Budget Start
2015-06-01
Budget End
2016-05-31
Support Year
13
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Whitehead Institute for Biomedical Research
Department
Type
DUNS #
120989983
City
Cambridge
State
MA
Country
United States
Zip Code
Roessler, Reinhard; Goldmann, Johanna; Shivalila, Chikdu et al. (2018) JIP2 haploinsufficiency contributes to neurodevelopmental abnormalities in human pluripotent stem cell-derived neural progenitors and cortical neurons. Life Sci Alliance 1:e201800094
Ma, Haiting; Wert, Katherine J; Shvartsman, Dmitry et al. (2018) Establishment of human pluripotent stem cell-derived pancreatic ?-like cells in the mouse pancreas. Proc Natl Acad Sci U S A 115:3924-3929
Cohen, Malkiel A; Markoulaki, Styliani; Jaenisch, Rudolf (2018) Matched Developmental Timing of Donor Cells with the Host Is Crucial for Chimera Formation. Stem Cell Reports 10:1445-1452
Muffat, Julien; Li, Yun; Omer, Attya et al. (2018) Human induced pluripotent stem cell-derived glial cells and neural progenitors display divergent responses to Zika and dengue infections. Proc Natl Acad Sci U S A 115:7117-7122
Harikumar, Arigela; Edupuganti, Raghu Ram; Sorek, Matan et al. (2017) An Endogenously Tagged Fluorescent Fusion Protein Library in Mouse Embryonic Stem Cells. Stem Cell Reports 9:1304-1314
Sahakyan, Anna; Kim, Rachel; Chronis, Constantinos et al. (2017) Human Naive Pluripotent Stem Cells Model X Chromosome Dampening and X Inactivation. Cell Stem Cell 20:87-101
Oh, Chang-Ki; Sultan, Abdullah; Platzer, Joseph et al. (2017) S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson's Disease Models. Cell Rep 21:2171-2182
Liu, X Shawn; Wu, Hao; Ji, Xiong et al. (2016) Editing DNA Methylation in the Mammalian Genome. Cell 167:233-247.e17
Soldner, Frank; Stelzer, Yonatan; Shivalila, Chikdu S et al. (2016) Parkinson-associated risk variant in distal enhancer of ?-synuclein modulates target gene expression. Nature 533:95-9
Theunissen, Thorold W; Friedli, Marc; He, Yupeng et al. (2016) Molecular Criteria for Defining the Naive Human Pluripotent State. Cell Stem Cell 19:502-515

Showing the most recent 10 out of 80 publications